Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

78 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Long-Term Effect of Home Blood Pressure Self-Monitoring Plus Medication Self-Titration for Patients With Hypertension: A Secondary Analysis of the ADAMPA Randomized Clinical Trial.
Martínez-Ibáñez P, Marco-Moreno I, García-Sempere A, Peiró S, Martínez-Ibáñez L, Barreira-Franch I, Bellot-Pujalte L, Avelino-Hidalgo E, Escrig-Veses M, Bóveda-García M, Calleja-Del-Ser M, Robles-Cabaniñas C, Hurtado I, Rodríguez-Bernal CL, Giménez-Loreiro M, Sanfélix-Gimeno G, Sanfélix-Genovés J; ADAMPA Research Group. Martínez-Ibáñez P, et al. JAMA Netw Open. 2024 May 1;7(5):e2410063. doi: 10.1001/jamanetworkopen.2024.10063. JAMA Netw Open. 2024. PMID: 38728033 Clinical Trial.
Increasing the complexity of lipoprotein characterization for cardiovascular risk in type 2 diabetes.
Guardiola M, Rehues P, Amigó N, Arrieta F, Botana M, Gimeno-Orna JA, Girona J, Martínez-Montoro JI, Ortega E, Pérez-Pérez A, Sánchez-Margalet V, Pedro-Botet J, Ribalta J; Cardiovascular Disease Group of the Spanish Society of Diabetes. Guardiola M, et al. Eur J Clin Invest. 2024 Apr 13:e14214. doi: 10.1111/eci.14214. Online ahead of print. Eur J Clin Invest. 2024. PMID: 38613414 Review.
Author Correction: A new risk score to assess atrial fibrillation risk in hypertensive patients (ESCARVAL-RISK Project.
Orozco-Beltran D, Quesada JA, Bertomeu-Gonzalez V, Lobos-Bejarano JM, Navarro-Perez J, Gil-Guillen VF, Ortiz LG, Lopez-Pineda A, Castellanos-Rodriguez A, Lopez-Domenech A, Cardona-Llorens AFJ, Carratala-Munuera C. Orozco-Beltran D, et al. Among authors: navarro perez j. Sci Rep. 2023 Aug 16;13(1):13297. doi: 10.1038/s41598-023-40306-2. Sci Rep. 2023. PMID: 37587145 Free PMC article. No abstract available.
Safety and immunogenicity of the protein-based PHH-1V compared to BNT162b2 as a heterologous SARS-CoV-2 booster vaccine in adults vaccinated against COVID-19: a multicentre, randomised, double-blind, non-inferiority phase IIb trial.
Corominas J, Garriga C, Prenafeta A, Moros A, Cañete M, Barreiro A, González-González L, Madrenas L, Güell I, Clotet B, Izquierdo-Useros N, Raïch-Regué D, Gallemí M, Blanco J, Pradenas E, Trinité B, Prado JG, Blanch-Lombarte O, Pérez-Caballero R, Plana M, Esteban I, Pastor-Quiñones C, Núñez-Costa X, Taleb RA, McSkimming P, Soriano A, Nava J, Anagua JO, Ramos R, Lluch RM, Comes AC, Romero SO, Gomez XM, Sans-Pola C, Moltó J, Benet S, Bailón L, Arribas JR, Borobia AM, Parada JQ, Navarro-Pérez J, Forner Giner MJ, Lucas RO, Jiménez MDMV, Compán SO, Alvarez-Mon M, Troncoso D, Arana-Arri E, Meijide S, Imaz-Ayo N, García PM, de la Villa Martínez S, Fernández SR, Prat T, Torroella È, Ferrer L. Corominas J, et al. Among authors: navarro perez j. Lancet Reg Health Eur. 2023 May;28:100613. doi: 10.1016/j.lanepe.2023.100613. Epub 2023 Apr 14. Lancet Reg Health Eur. 2023. PMID: 37131861 Free PMC article.
78 results